Evidence map›Paper›PMID 38751533›Full record

ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2022

Risk-reducing surgery in

Monika K Masanam, Clark W Pitcher, Olutayo Sogunro, Leah K Starks, Allison B Murray, Marc E Boisvert

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational breast cancer research : a journal focusing on translational research in breast cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. GermlineGenes · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Monika K MasanamDepartment of Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
Clark W PitcherGeorgetown University School of Medicine, Washington, DC, USA.
Olutayo SogunroDivision of Breast Surgery, Department of Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
Leah K StarksDepartment of Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
Allison B MurrayDivision of Breast Surgery, Department of Surgery, MedStar Georgetown University Hospital, Washington, DC, USA.
Marc E BoisvertDivision of Breast Surgery, Department of Surgery, MedStar Washington Hospital Center, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inherited germline mutations in Methods: In this retrospective observational study, we present 5 patients with Results: Out of the 5 patients, 3 patients underwent CRRM and 2 patients chose unilateral surgery for their breast cancer and active surveillance for the contralateral breast. Of the 3 patients who underwent CRRM, 1 patient experienced a surgical complication from reconstruction on the prophylactic side. None of the patients developed any recurrences with an average length of follow up of 15.4 months. Conclusions: Based on our experience and the currently available literature, CRRM in patients with a

Indexed as

breast cancercase seriesmastectomyPALB2 mutationsrisk reduction

Identifiers

PMID38751533
PMCPMC11093008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.